The objective of this study was to compare the efficacy and the safety of bisoprolol (B) and acebutolol (A) on blood pressure at rest and during exercise in hypertensives. The design was a comparative, single-blind study with two phases following a 10-day washout period for pretreated patients: a 15 day-placebo phase and an 8-week therapeutic phase. Forty-six outpatients suffering from mild to moderate essential hypertension [diastolic blood pressure (DBP) ranging between 95 and 120 mm Hg] were randomly given either 10 mg of bisoprolol or 400 mg of acebutolol once a day for 8 weeks; this dosage was doubled after 4 weeks if DBP was still above 90 mm Hg. Blood pressure measurements were made 24 h after drug intake at rest and during exercise stress tests and were performed at the end of the placebo period and after 1 and 2 months of active treatment. Serum lipid levels were also measured before and at the end of the study. Forty-four patients (21 B/23 A) were analyzed for resting blood pressures and 33 (15 B/18 A) for exercise blood pressure profile. At the end of the first month of treatment, a significant decrease (p < 0.001) in supine and upright systolic (SBP) and DBP was noted in both groups. The reduction in supine DBP after 4 weeks was significantly greater with B (p = 0.036). A further decrease of blood pressure was observed in both groups during the second month of treatment, which was significant only in supine SBP (p < 0.05). After 2 months, the heart rate decreased by 24% with B and 13% with A (B vs. A; p = 0.002). Regarding the BP profile during exercise, B and A caused a similar and significant reduction in both SBP and DBP (p < 0.001). The reduction in heart rate during exercise was more marked with B, with no significant difference between the two groups. Side effects were reported in three patients on B and six on A. Both at rest and during exercise, at a level of effort similar to that of daily activities, B exerted a hypotensive effect at least equivalent to that of A in mild and moderate hypertensive patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

blood pressure
28
rest exercise
12
bisoprolol acebutolol
8
blood
8
resting blood
8
exercise blood
8
pressure profile
8
hypertensive patients
8
comparative single-blind
8
single-blind study
8

Similar Publications

Background: Understanding based on up-to-date data on the burden of non-communicable diseases (NCDs) is limited, especially regarding how subtypes contribute to the overall NCD burden and the attributable risk factors across locations and subtypes. We aimed to report the global, regional, and national burden of NCDs, subtypes, and attributable risk factors in 2021, and trends from 1990 to 2021 by age, sex, and socio-demographic index (SDI).

Materials And Methods: We used data from the Global Burden of Disease Study 2021 to estimate the prevalence, deaths, and disability-adjusted life years (DALYs) for NCDs and subtypes, along with attributable risk factors.

View Article and Find Full Text PDF

Severe bradycardia in patients with obstructive sleep apnoea and good early response to CPAP.

Sleep Breath

January 2025

Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Prądnicka 80, Kraków, 31-202, Poland.

Background: Obstructive sleep apnoea (OSA) may lead to heart rhythm abnormalities including bradycardia. Our aim was to ascertain clinical and echocardiographic parameters in patients with OSA in whom severe bradycardia was detected in an outpatient setting, as well as to evaluate the efficacy of CPAP therapy on heart rate normalization at the early stages of treatment.

Methods: Fifteen patients mild, moderate or severe OSA and concomitant bradycardia were enrolled.

View Article and Find Full Text PDF

Mediation of modifiable risk factors in two multidomain dementia prevention trials.

Alzheimers Dement

January 2025

Department of Public and Occupational Health, Amsterdam UMC Location VUMC, Amsterdam, the Netherlands.

Introduction: We explored which dementia risk factors in two multidomain prevention trials mediate beneficial, neutral, or counteracting effects on dementia incidence.

Methods: We pooled data from the multidomain MAPT (Multidomain Alzheimer Preventive Trial; n = 1679, up to 5-year follow-up) and preDIVA trials (Prevention of Dementia by Intensive Vascular Care; n = 3526, up to 12-year follow-up) in adults aged 70+. We used multiple mediation analysis to quantify the role of 2-year changes in body mass index, systolic blood pressure, total cholesterol, and physical activity in the intervention effects on dementia incidence.

View Article and Find Full Text PDF

Background: Membrane oxygenators facilitate extracorporeal gas exchange, necessitating the monitoring of blood gas. Recent advances in normothermic machine perfusion (NMP) for ex vivo liver offer solutions to the shortage of donor liver. However, maintaining physiological blood gas levels during prolonged NMP is complex and costly.

View Article and Find Full Text PDF

Associations of Faith Community Rejection with Social Support and Health Outcomes among LGBTQ+ Older Adults.

J Gerontol B Psychol Sci Soc Sci

January 2025

Department of Medicine, Health, and Society, Vanderbilt University, Nashville, Tennessee, USA.

Objectives: Lesbian, gay, bisexual, transgender, and queer (LGBTQ+) older adults have varied experiences with faith communities, ranging from affirmation to religious trauma. We investigate how faith community rejection impacts social support and health outcomes among LGBTQ+ older adults in the Southern United States.

Methods: We analyze Wave 1 data from the LGBTQ+ Social Networks, Aging, and Policy Study (QSNAPS), collected between April 2020 and September 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!